BUY MBP MELPHALAN MEGVAL 50MG VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Melphalan is a chemotherapy medicine used to treat certain types of cancer, particularly multiple myeloma and, in some cases, ovarian cancer. It belongs to a group of medicines known as alkylating agents. These medicines work by damaging the DNA inside cancer cells, which prevents them from growing, dividing, and surviving. Because cancer cells divide more rapidly than most normal cells, they are more affected by melphalan, although some healthy cells can also be affected.

Melphalan works by forming cross-links within DNA strands. This damage prevents cancer cells from replicating properly and eventually leads to cell death. Because this action is not selective only for cancer cells, melphalan can also affect normal fast-growing cells such as those in the bone marrow, digestive tract, and hair follicles. This explains many of its side effects.

Melphalan can be given in two main ways, either orally as tablets or intravenously as an injection, depending on the condition being treated and the treatment plan. In multiple myeloma, melphalan may be used alone or in combination with other medicines such as steroids. In some patients, high-dose melphalan is used before a stem cell transplant to destroy cancerous bone marrow cells before healthy stem cells are infused.

When taken by mouth, melphalan should be taken exactly as prescribed, usually on an empty stomach to improve absorption. The dose is carefully calculated based on body weight, kidney function, and overall health. Because melphalan can suppress bone marrow function, regular blood tests are essential to monitor blood cell counts and ensure safe treatment.

One of the most important effects of melphalan is bone marrow suppression. This can lead to low white blood cell counts, increasing the risk of infection; low red blood cell counts, causing fatigue and shortness of breath; and low platelet counts, increasing the risk of bruising and bleeding. These effects are usually temporary but can be severe, especially with higher doses.

Other common side effects include nausea, vomiting, loss of appetite, mouth sores, and diarrhoea. Hair thinning or hair loss may also occur, especially with higher doses. Some people experience skin rashes or changes in skin colour. With long-term use, melphalan can increase the risk of developing secondary cancers, although this is uncommon and usually outweighed by its benefits in treating serious disease.

Melphalan can also affect fertility in both men and women. It may cause temporary or permanent infertility, so fertility preservation options should be discussed before starting treatment if future childbearing is desired. Melphalan must not be used during pregnancy, as it can cause serious harm to an unborn baby. Effective contraception is required during treatment and for a period afterward.

Patients receiving melphalan should avoid close contact with people who have infections and should report signs such as fever, sore throat, unusual bruising, bleeding, or extreme fatigue immediately. Vaccinations with live vaccines should be avoided during treatment unless approved by a healthcare provider.

Melphalan can interact with other medications, including some chemotherapy drugs, immunosuppressants, and vaccines. It is important to inform the healthcare team of all medicines, supplements, and herbal products being taken.

Despite its potential side effects, melphalan remains an important and effective treatment for certain cancers, especially multiple myeloma. With careful monitoring, appropriate dose adjustments, and supportive care, many patients benefit significantly from treatment. Regular follow-up and close communication with the healthcare team are essential to ensure safety and achieve the best possible outcomes.